Search results
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 3 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with ...
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 3 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 2 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 18 hours agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 2 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 19 hours agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 6 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Amgen (AMGN) Scheduled to Post Earnings on Thursday
ETF DAILY NEWS· 4 days agoAmgen (NASDAQ:AMGN – Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of $3.82 per share ...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 6 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number of other analysts ...
